{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:01:43Z","timestamp":1746331303594,"version":"3.40.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270834"],"award-info":[{"award-number":["82270834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ncrna.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T08:24:33Z","timestamp":1736324673000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of MALAT1 facilitates ROS accumulation via the Keap1\/HO-1 pathway to enhance photodynamic therapy in secondary hyperparathyroidism"],"prefix":"10.1016","volume":"11","author":[{"given":"Ying","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiejia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-4925","authenticated-orcid":false,"given":"Wenjun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ncrna.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.14.1.18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"14","author":"Andress","year":"2008","journal-title":"Endocr. Pract."},{"issue":"6","key":"10.1016\/j.ncrna.2024.12.001_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am. J. Kidney Dis. : Offi. J. Nat. Kidney Found."},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.001_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40265-016-0575-2","article-title":"Pharmacological management of secondary hyperparathyroidism in patients with chronic kidney disease","volume":"76","author":"Salam","year":"2016","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.001_bib7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/13543784.2024.2369307","article-title":"Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs","volume":"33","author":"Magagnoli","year":"2024","journal-title":"Expet Opin. Invest. Drugs."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/bjs.9661","article-title":"Role of surgery in the treatment of renal secondary hyperparathyroidism","volume":"102","author":"Schneider","year":"2015","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib9","first-page":"825","article-title":"Surgical management of secondary and tertiary hyperparathyroidism","volume":"104","author":"Bartz-Kurycki","year":"2024","journal-title":"Surg. Clin."},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.001_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/tcr.201600121","article-title":"Photodynamic therapy: past, present and future","volume":"17","author":"Chilakamarthi","year":"2017","journal-title":"Chem. Rec."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2003.09.002","article-title":"Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters","volume":"56","author":"Lopez","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ncrna.2024.12.001_bib12","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ncrna.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/MLG.0b013e3181671b61","article-title":"Rosenthal EL: fluorescent detection of rat parathyroid glands via 5-aminolevulinic acid","volume":"118","author":"Asher","year":"2008","journal-title":"Laryngoscope"},{"issue":"23","key":"10.1016\/j.ncrna.2024.12.001_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316890","article-title":"Cellular mechanisms of singlet oxygen in photodynamic therapy","volume":"24","author":"Przygoda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib15","first-page":"821","article-title":"Photolon\u2122 --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes","volume":"39","author":"Ali-Seyed","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.ncrna.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/jacsau.2c00591","article-title":"Immuno-photodynamic therapy (IPDT): organic photosensitizers and their application in cancer ablation","volume":"3","author":"Lu","year":"2023","journal-title":"JACS Au"},{"issue":"23","key":"10.1016\/j.ncrna.2024.12.001_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314689","article-title":"Possible mechanisms of resistance development to photodynamic therapy (PDT) in vulvar cancer cells","volume":"23","author":"Mossakowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.ncrna.2024.12.001_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710133","article-title":"Reactive oxygen species and long non-coding RNAs, an unexpected crossroad in cancer cells","volume":"23","author":"Kacso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-021-01488-3","article-title":"The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role","volume":"21","author":"Zuo","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2024.12.001_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8184314","article-title":"LncRNA MALAT1 regulates miR-144-3p to facilitate epithelial-mesenchymal transition of lens epithelial cells via the ROS\/NRF2\/Notch1\/Snail pathway","volume":"2020","author":"Ye","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.ncrna.2024.12.001_bib21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ekir.2019.09.007","article-title":"Kidney disease: improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update implementation: asia summit conference report","volume":"4","author":"Wang","year":"2017","journal-title":"Kidney Intern. Rep."},{"key":"10.1016\/j.ncrna.2024.12.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111994","article-title":"Inhibition of autophagy with Chloroquine enhanced apoptosis induced by 5-aminolevulinic acid-photodynamic therapy in secondary hyperparathyroidism primary cells and organoids","volume":"142","author":"Zeng","year":"2021","journal-title":"Biomed. pharmacotherapy"},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s43630-023-00361-0","article-title":"RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism","volume":"22","author":"Wen","year":"2023","journal-title":"Photochem. Photobiol. Sci. : Offic. J. European Photochem. Assoc. European Soc. Photobio."},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.001_bib24","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300209R","article-title":"Effects of evocalcet on parathyroid calcium-sensing receptor and vitamin D receptor expression in uremic rats","volume":"37","author":"Saito","year":"2023","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10157-016-1335-z","article-title":"Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats","volume":"21","author":"Miyakogawa","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12951-021-01077-y","article-title":"Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence","volume":"19","author":"Zheng","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.001_bib27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/1440-1681.13673","article-title":"Hemin mitigates contrast-induced nephropathy by inhibiting ferroptosis via HO-1\/Nrf2\/GPX4 pathway","volume":"49","author":"Gao","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ncrna.2024.12.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175085","article-title":"Sodium salicylate induces browning of white adipocytes via M2 macrophage polarization by HO-1 upregulation","volume":"928","author":"Choi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ncrna.2024.12.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2021.09.002","article-title":"Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3\u03b2 and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease","volume":"34","author":"Bian","year":"2021","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.ncrna.2024.12.001_bib30","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/15548627.2022.2039535","article-title":"Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations","volume":"18","author":"Xu","year":"2022","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.ncrna.2024.12.001_bib31","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/s41401-023-01112-8","article-title":"Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-7563.2012.01535.x","article-title":"MG132, a proteasome inhibitor, induces apoptosis in tumor cells","volume":"9","author":"Guo","year":"2013","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.ncrna.2024.12.001_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27206848","article-title":"Development of biotechnological photosensitizers for photodynamic therapy: cancer research and treatment-from benchtop to clinical practice","volume":"27","author":"Aires-Fernandes","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.001_bib34","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/app11083626","article-title":"Photodynamic therapy\u2014an up-to-date review","volume":"11","author":"Niculescu","year":"2021","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pdpdt.2009.03.002","article-title":"Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer?","volume":"6","author":"Nyst","year":"2009","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.ncrna.2024.12.001_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pdpdt.2015.07.175","article-title":"Photodynamic therapy in colorectal cancer treatment--The state of the art in preclinical research","volume":"13","author":"Kawczyk-Krupka","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"10","key":"10.1016\/j.ncrna.2024.12.001_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317734691","article-title":"Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells","volume":"39","author":"Hodgkinson","year":"2017","journal-title":"Tumour biology : J. Intern. Soc. Oncodev. Biol. Med."},{"issue":"15","key":"10.1016\/j.ncrna.2024.12.001_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512204","article-title":"Photodynamic therapy for colorectal cancer: an update and a look to the future","volume":"24","author":"Rodrigues","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.001_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ncrna.2024.01.015","article-title":"Long noncoding RNA MALAT-1: a versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance","volume":"9","author":"Xu","year":"2024","journal-title":"Non-coding RNA research"},{"issue":"7","key":"10.1016\/j.ncrna.2024.12.001_bib40","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/00207454.2021.1972999","article-title":"LncRNA MALAT1 improves cerebral ischemia-reperfusion injury and cognitive dysfunction by regulating miR-142-3p\/SIRT1 axis","volume":"133","author":"Meng","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ncrna.2024.12.001_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122209","article-title":"Nrf2\/HO-1 as a therapeutic target in renal fibrosis","volume":"334","author":"Hassanein","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ncrna.2024.12.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.143753","article-title":"Activation of the ROS\/HO-1\/NQO1 signaling pathway contributes to the copper-induced oxidative stress and autophagy in duck renal tubular epithelial cells","volume":"757","author":"Fang","year":"2021","journal-title":"Sci. Total Environ."},{"issue":"9","key":"10.1016\/j.ncrna.2024.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10515","article-title":"tBHQ attenuates podocyte injury in diabetic nephropathy by inhibiting NADPH oxidase-derived ROS generation via the Nrf2\/HO-1 signalling pathway","volume":"8","author":"Liu","year":"2022","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.ncrna.2024.12.001_bib44","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","article-title":"Heme oxygenase-1 and carbon monoxide in the heart: the balancing act between danger signaling and pro-survival","volume":"118","author":"Otterbein","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12931-020-01358-4","article-title":"Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2\/HO-1 and inhibition of the NF-\u03baB pathways","volume":"21","author":"Dang","year":"2020","journal-title":"Respir. Res."},{"issue":"22","key":"10.1016\/j.ncrna.2024.12.001_bib46","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","article-title":"Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.001_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1\u2013Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Gene Cell. : Devo. Mole. Cell. Mechan."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib48","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbrc.2017.12.105","article-title":"The long non-coding RNA MALAT1 activates Nrf2 signaling to protect human umbilical vein endothelial cells from hydrogen peroxide","volume":"495","author":"Zeng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ncrna.2024.12.001_bib49","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"9","key":"10.1016\/j.ncrna.2024.12.001_bib50","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.001_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/db20-0375","article-title":"Long noncoding RNA MALAT1 and regulation of the antioxidant defense system in diabetic retinopathy","volume":"70","author":"Radhakrishnan","year":"2021","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.001_bib52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3892\/etm.2017.4095","article-title":"Long noncoding RNA MALAT1 inhibits apoptosis induced by oxygen-glucose deprivation and reoxygenation in human brain microvascular endothelial cells","volume":"13","author":"Xin","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ncrna.2024.12.001_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/502676","article-title":"The impact of autophagy on cell death modalities","volume":"2014","author":"Ryter","year":"2014","journal-title":"Int. J. Cell. Biol."},{"key":"10.1016\/j.ncrna.2024.12.001_bib54","article-title":"Role of the crosstalk between autophagy and apoptosis in cancer","volume":"2013","author":"Su","year":"2013","journal-title":"JAMA Oncol."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054024001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054024001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T03:05:14Z","timestamp":1746241514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054024001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":54,"alternative-id":["S2468054024001653"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2024.12.001","relation":{},"ISSN":["2468-0540"],"issn-type":[{"type":"print","value":"2468-0540"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of MALAT1 facilitates ROS accumulation via the Keap1\/HO-1 pathway to enhance photodynamic therapy in secondary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}